Pre-treatment with a DPP-4 Inhibitor is Infarct Sparing in Hearts from Obese, Pre-diabetic Rats

The role of incretins in cardiovascular control

(2009) Derek D. Mafong et al.   CURRENT HYPERTENSION REPORTS

The effects of glucagon-like peptide-1 on the beta cell

(2009) T. Vilsbøll   DIABETES OBESITY & METABOLISM

Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways

(2008) Kiwon Ban et al.   CIRCULATION

The islet enhancer vildagliptin: mechanisms of improved glucose metabolism

(2008) B. Ahrén et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Future perspectives on glucagon-like peptide-1, diabetes and cardiovascular risk

(2008) E. Mannucci et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Efficacy of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide (P32/98) in fatty Zucker rats with incipient and manifest impaired glucose tolerance

(2007) P. Augstein et al.   DIABETES OBESITY & METABOLISM